Windtree Therapeutics (WINT) is being pushed off the Nasdaq exchange after its stock price collapsed, losing over 99% of its value year-to-date.
The delisting, triggered by a failure to maintain the mandatory $1 minimum bid price, highlights the severe financial distress of the company. This move follows a similar action against bitcoin miner Argo Blockchain in July, underscoring the regulatory rigor of Nasdaq’s listing standards.
For investors, the delisting to an over-the-counter market often means reduced liquidity and greater volatility, compounding the substantial losses already suffered.
